Research and analysis

Young person and adult screening KPI data: Q4 summary factsheets (1 January to 31 March 2022)

Updated 23 March 2023

Applies to England

Please be aware that this data covers the time period through the COVID-19 pandemic. Provider performance should therefore be interpreted with caution.

In addition to this, some providers were justifiably not able to make timely data returns or validate their data in this period. We recommend looking at the historical trend data of services before the COVID-19 pandemic to help interpret the data.

This report should be read in conjunction with the full key performance indicator (KPI) data tables published each quarter.

1. Abdominal aortic aneurysm screening

1.1 KPI AA2: coverage: initial screen

National performance of AA2 (see standard AAA-S04) in Q4 was 59.5%. AA2 is an annual indicator and quarterly figures are cumulative from Q1 to Q4. England performance is shown in the trend graph below.

Due to the ongoing coronavirus response and restoration of screening this KPI has been impacted. Performance against the KPI has been affected by when providers restarted primary screening, increased appointment lengths, access to venues and availability of screening staff.

Quarter 4 performance

Reporting period Numerator Denominator Performance % Completeness of data %
1 January to 31 March 2022 184,493 310,089 59.5% 100%
Region Performance %
East of England  56.5%
London 47.8%
Midlands 72.6%
North East and Yorkshire 54.4%
North West 34.3%
South East 66.1%
South West 79.6%
England 59.5%

1.2 KPI AA3: coverage: annual surveillance scan

National performance of AA3 (see standard AAA-S05) was withdrawn from publication in Q1 and Q2 2020 to 2021, and also Q1 2021 to 2022. This was due to the impact of the COVID-19 pandemic on screening activity that occurred during these periods.

The trend graph below shows that England AA3 in Q4 was 90.8%, above the acceptable threshold of 85%.

Quarter 4 performance

Reporting period Numerator Denominator Performance % Completeness of data %
1 January to 31 March 2022 2,677 2,948 90.8% 100%
Region Performance %
East of England  92.0%
London 87.6%
Midlands 94.4%
North East and Yorkshire 92.3%
North West 85.6%
South East 89.1%
South West 90.6%
England 90.8%

1.3 KPI AA4: coverage: quarterly surveillance scan

National performance of AA4 (see standard AAA-S06) was withdrawn from publication in Q1 and Q2 2020 to 2021 due to the impact of the COVID-19 pandemic on screening activity. The trend graph below shows that England AA4 in Q4 2021 to 2022 was 92.7%, lower than the previous quarter abut above the acceptable threshold of 90%.

Of 38 screening services, 29 met the acceptable threshold, and 11 met the achievable threshold of 95%.

Quarter 4 performance

Reporting period Numerator Denominator Performance % Completeness of data %
1 January to 31 March 2022 2,608 2,812 92.7% 100%
Region Performance %
East of England  95.1%
London 91.3%
Midlands 93.8%
North East and Yorkshire 93.9%
North West 89.0%
South East 90.7%
South West 92.7%
England 92.7%

2. Diabetic eye screening

2.1 KPI DE1: uptake: routine digital screening

National performance of DE1 (see standard DES-S07) in Q4 was 78.4%, higher than the previous 7 quarters. The trend graph below shows that England DE1 performance has been above the acceptable threshold of 75% for 3 consecutive quarters. All 57 screening services submitted data. DE1 is an annual rolling figure.

Due to the ongoing coronavirus response and restoration of screening this KPI may be impacted. Local services should highlight this with their commissioners.

Quarter 4 performance

Reporting period Numerator Denominator Performance % Completeness of data %
1 January to 31 March 2022 2,245,339 2,863,056 78.4% 100%
Region Performance %
East of England  83.0%
London 78.5%
Midlands 73.2%
North East and Yorkshire 78.8%
North West 75.0%
South East 81.8%
South West 83.2%
England 78.4%

2.2 KPI DE2: test: timeliness of results letters

National performance of DE2 (see standard DES-S10) in Q4 was 93.3%, lower than the previous quarter. The trend graph below shows that England DE2 performance fell below the achievable threshold of 95% for the first time since 1 July 2018. All 57 screening services submitted data; 54 services met the acceptable threshold of 70% and 44 met the achievable threshold of 95%.

Due to the ongoing coronavirus response and restoration of screening this KPI may be impacted. Local services should highlight this with their commissioners where they consider that this KPI has been impacted by the COVID-19 response.

Quarter 4 performance

Reporting period Numerator Denominator Performance % Completeness of data %
1 January to 31 March 2022 661,796 709,280 93.3% 100%
Region Performance %
East of England  99.5%
London 93.8%
Midlands 89.2%
North East and Yorkshire 88.2%
North West 87.5%
South East 99.8%
South West 98.3%
England 93.3%

2.3 KPI DE3: intervention/treatment: timely consultation for people with diabetes who are screen positive

National performance of DE3 (see standard DES-S12) in Q4 was 65.5%, lower than the previous 7 quarters. The trend graph below shows that England DE3 performance has remained below the acceptable threshold of 80% since 1 April 2018. All 57 screening services submitted data and 15 met the acceptable threshold.

Due to the ongoing coronavirus response and restoration of screening this KPI may be impacted. Local services should highlight this with their commissioners where they consider that this KPI has been impacted by the COVID-19 response.

Quarter 4 performance

Reporting period Numerator Denominator Performance % Completeness of data %
1 January to 31 March 2022 1,847 2,818 65.5% 100%
Region Performance %
East of England  58.1%
London 68.3%
Midlands 67.7%
North East and Yorkshire 68.0%
North West 66.5%
South East 69.3%
South West 56.4%
England 65.5%

3. Bowel cancer screening

3.1 KPI BCS1: uptake

National performance of BCS1 (see standard BCSP-S02) in Q4 was 67.0%, higher than the previous quarter. Publication of BCS1 was withdrawn for Q1 2020 to 2021 due to the impact of COVID-19 on screening activity. The trend graph below shows that England BCS1 performance has remained above the acceptable threshold of 52% since 1 April 2018.

Out of 64 screening services, 62 of them met the acceptable threshold and 57 met the achievable threshold of 60%.

Quarter 4 performance

Reporting period Numerator Denominator Performance % Completeness of data %
1 January to 31 March 2022 937,369 1,398,500 67.0% 100%
Region Performance %
East of England  68.7%
London 56.7%
Midlands 67.0%
North East and Yorkshire 69.6%
North West 66.3%
South East 68.9%
South West 71.4%
England 67.0%

3.2 KPI BCS2: coverage

National performance of BCS2 (see standard BCSP-S01) in Q3 was 70.1%, the highest published level recorded for this KPI. See the corresponding data tables for Q3 2021 to 2022 for full details.

BCS2 is available 6 months (2 quarters) in arrears. The trend graph below shows England BCS2 performance since 1 April 2018. There are no thresholds set for this KPI.

Activity for Q3 is presented by Public Health England (PHE) regions (valid at the time of data collection). Coverage ranged from 62.1% in London to 73.1% in the South.

Quarter 3 performance

Reporting period Numerator Denominator Performance % Completeness of data %
1 October to 31 December 2021 6,423,905 9,166,483 70.1% 100%
Region Performance %
London  62.1%
Midlands and East 70.5%
North 70.0%
South 73.1%
England 70.1%

4. Breast screening

4.1 KPI BS1: uptake

National performance of BS1 (see standard BSP-S03) in Q4 was 53.3%. The England trend graph below shows that publication of this KPI was withdrawn from Q1 to Q4 2020 to 2021 as there were issues with data quality due to the impact of the COVID-19 pandemic on screening services.

Provisional quarterly data should be used with caution to measure performance as it will contain a proportion of women who were invited but have not yet attended the appointment. Data on this indicator will only be accurate 6 months after the end of the reporting period.

Quarter 4 performance

Reporting period Numerator Denominator Performance % Completeness of data %
1 January to 31 March 2022 453,638 851,648 53.3% 100%
Region Performance %
East of England  53.6%
London 37.0%
Midlands 54.1%
North East and Yorkshire 58.3%
North West 53.0%
South East 61.9%
South West 56.8%
England 53.3%

4.2 KPI BS2: uptake: screening round length

National performance of BS2 (see standard BSP-S04) in Q4 was 45.7%. The England trend graph below shows that publication of this KPI was withdrawn from Q1 to Q4 2020 to 2021 as there were issues with data quality due to the impact of the COVID-19 pandemic on screening services.

Quarter 4 performance

Reporting period Numerator Denominator Performance % Completeness of data %
1 January to 31 March 2022 294,220 644,230 45.7% 100%
Region Performance %
East of England  64.1%
London 26.4%
Midlands 40.7%
North East and Yorkshire 52.9%
North West 37.2%
South East 58.8%
South West 43.7%
England 45.7%

5. Cervical screening

5.1 KPI CS1: coverage under 50 years

National performance of CS1 (see standard CSP-S01) in Q4 was 68.6%, which was above the previous quarter. The trend graph below shows that CS1 performance has remained below the acceptable threshold of 80% since 1 April 2018.

On April 1 2021, 38 clinical commissioning groups (CCGs) merged to form 9 new ones, resulting in a total of 106 CCGs in England. None of the 106 CCGs met the acceptable threshold.

Quarter 4 performance

Reporting period Numerator Denominator Performance % Completeness of data %
1 January to 31 March 2022 7,144,046 10,408,742 68.6% 100%
Region Performance %
East of England  71.4%
London 61.2%
Midlands 69.6%
North East and Yorkshire 71.8%
North West 69.4%
South East 70.2%
South West 72.9%
England 68.6%

5.2 KPI CS2: coverage 50 years and above

National performance of CS2 (see standard CSP-S02) in Q4 was 75.0%, slightly higher than the previous quarter. The trend graph below shows that CS2 performance has remained below the acceptable threshold of 80% since 1 April 2018.

On April 1 2021, 38 CCGs merged to form 9 new ones, resulting in a total of 106 CCGs in England. None of the 106 CCGs met the acceptable threshold.

Quarter 4 performance

Reporting period Numerator Denominator Performance % Completeness of data %
1 January to 31 March 2022 3,987,479 5,315,681 75.0% 100%
Region Performance %
East of England  76.3%
London 71.8%
Midlands 75.5%
North East and Yorkshire 76.3%
North West 74.0%
South East 75.2%
South West 76.5%
England 75.0%